A critical role for p38MAPK signalling pathway during reprogramming of human fibroblasts to iPSCs View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-02-03

AUTHORS

Irina Neganova, Valeria Chichagova, Lyle Armstrong, Majlinda Lako

ABSTRACT

Reprogramming of somatic cells to induced pluripotent stem cells (iPSCs) holds enormous promise for regenerative medicine. Reprogramming is a stepwise process with well-defined stages of initiation, maturation and stabilisation which are critically dependent on interactions between key pluripotency transcription factors, epigenetic regulators and signalling pathways. In this manuscript we have investigated the role of p38 MAPK signalling pathway and have shown a subpopulation- and phase-specific pattern of activation occurring during the initiation and maturation stage of reprogramming in partially and fully reprogrammed cells respectively. Downregulation of p38 MAPK activity via RNA interference or small molecule inhibitor led to cell accumulation in G1 phase of the cell cycle and reduced expression of cell cycle regulators during the initiation stage of reprogramming. This was associated with a significant downregulation of key pluripotency marker expression, disruption of mesenchymal to epithelial transition (MET), increased expression of differentiation markers and presence of partially reprogrammed cells which retained a typical gene expression profile of mesendodermal cells and were unable to progress to fully reprogrammed phenotype. Together our data indicate an important role for p38 MAPK activity in proliferation, MET progression and establishment of pluripotent phenotype, which are necessary steps for the development of human iPSCs. More... »

PAGES

41693

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/srep41693

DOI

http://dx.doi.org/10.1038/srep41693

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1083524755

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28155868


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biological Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biochemistry and Cell Biology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0604", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Genetics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Cycle", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cells, Cultured", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cellular Reprogramming", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Epithelial-Mesenchymal Transition", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fibroblasts", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression Regulation, Developmental", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Induced Pluripotent Stem Cells", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "MAP Kinase Signaling System", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Kinase Inhibitors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Institute of Genetic Medicine, Newcastle University, International Centre for Life, NE1 3BZ, UK", 
          "id": "http://www.grid.ac/institutes/grid.1006.7", 
          "name": [
            "Institute of Genetic Medicine, Newcastle University, International Centre for Life, NE1 3BZ, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Neganova", 
        "givenName": "Irina", 
        "id": "sg:person.01162446171.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162446171.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Genetic Medicine, Newcastle University, International Centre for Life, NE1 3BZ, UK", 
          "id": "http://www.grid.ac/institutes/grid.1006.7", 
          "name": [
            "Institute of Genetic Medicine, Newcastle University, International Centre for Life, NE1 3BZ, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chichagova", 
        "givenName": "Valeria", 
        "id": "sg:person.01366133637.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01366133637.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Genetic Medicine, Newcastle University, International Centre for Life, NE1 3BZ, UK", 
          "id": "http://www.grid.ac/institutes/grid.1006.7", 
          "name": [
            "Institute of Genetic Medicine, Newcastle University, International Centre for Life, NE1 3BZ, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Armstrong", 
        "givenName": "Lyle", 
        "id": "sg:person.01165132537.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01165132537.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Genetic Medicine, Newcastle University, International Centre for Life, NE1 3BZ, UK", 
          "id": "http://www.grid.ac/institutes/grid.1006.7", 
          "name": [
            "Institute of Genetic Medicine, Newcastle University, International Centre for Life, NE1 3BZ, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lako", 
        "givenName": "Majlinda", 
        "id": "sg:person.01007342000.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01007342000.45"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/onc.2011.656", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024757614", 
          "https://doi.org/10.1038/onc.2011.656"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ncb3207", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032373249", 
          "https://doi.org/10.1038/ncb3207"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature09531", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025900132", 
          "https://doi.org/10.1038/nature09531"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature14607", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011151247", 
          "https://doi.org/10.1038/nature14607"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/onc.2008.358", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021627237", 
          "https://doi.org/10.1038/onc.2008.358"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ncomms4678", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003699666", 
          "https://doi.org/10.1038/ncomms4678"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/cr.2012.143", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053268375", 
          "https://doi.org/10.1038/cr.2012.143"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nchembio.1552", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023910067", 
          "https://doi.org/10.1038/nchembio.1552"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/cddis.2014.464", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015071629", 
          "https://doi.org/10.1038/cddis.2014.464"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ncomms2059", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005754768", 
          "https://doi.org/10.1038/ncomms2059"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature14047", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006413691", 
          "https://doi.org/10.1038/nature14047"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-02-03", 
    "datePublishedReg": "2017-02-03", 
    "description": "Reprogramming of somatic cells to induced pluripotent stem cells (iPSCs) holds enormous promise for regenerative medicine. Reprogramming is a stepwise process with well-defined stages of initiation, maturation and stabilisation which are critically dependent on interactions between key pluripotency transcription factors, epigenetic regulators and signalling pathways. In this manuscript we have investigated the role of p38 MAPK signalling pathway and have shown a subpopulation- and phase-specific pattern of activation occurring during the initiation and maturation stage of reprogramming in partially and fully reprogrammed cells respectively. Downregulation of p38 MAPK activity via RNA interference or small molecule inhibitor led to cell accumulation in G1 phase of the cell cycle and reduced expression of cell cycle regulators during the initiation stage of reprogramming. This was associated with a significant downregulation of key pluripotency marker expression, disruption of mesenchymal to epithelial transition (MET), increased expression of differentiation markers and presence of partially reprogrammed cells which retained a typical gene expression profile of mesendodermal cells and were unable to progress to fully reprogrammed phenotype. Together our data indicate an important role for p38 MAPK activity in proliferation, MET progression and establishment of pluripotent phenotype, which are necessary steps for the development of human iPSCs.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/srep41693", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2785655", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.5135071", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2769496", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.3791225", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2757148", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1045337", 
        "issn": [
          "2045-2322"
        ], 
        "name": "Scientific Reports", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "7"
      }
    ], 
    "keywords": [
      "p38 MAPK activity", 
      "key pluripotency transcription factors", 
      "MAPK activity", 
      "pluripotency transcription factors", 
      "typical gene expression profiles", 
      "gene expression profiles", 
      "phase-specific pattern", 
      "cell cycle regulators", 
      "pluripotent stem cells", 
      "small molecule inhibitors", 
      "pluripotency marker expression", 
      "mesendodermal cells", 
      "epigenetic regulators", 
      "transcription factors", 
      "somatic cells", 
      "pluripotent phenotype", 
      "RNA interference", 
      "cycle regulators", 
      "expression profiles", 
      "cell cycle", 
      "epithelial transition", 
      "p38 MAPK", 
      "molecule inhibitors", 
      "G1 phase", 
      "stem cells", 
      "human iPSC", 
      "differentiation markers", 
      "human fibroblasts", 
      "reduced expression", 
      "regenerative medicine", 
      "maturation stage", 
      "significant downregulation", 
      "critical role", 
      "pathway", 
      "regulator", 
      "expression", 
      "stage of initiation", 
      "phenotype", 
      "cells", 
      "marker expression", 
      "enormous promise", 
      "downregulation", 
      "initiation stage", 
      "stepwise process", 
      "important role", 
      "reprogramming", 
      "MetS progression", 
      "MAPK", 
      "role", 
      "iPSCs", 
      "cell accumulation", 
      "p38MAPK", 
      "iPSCs", 
      "fibroblasts", 
      "maturation", 
      "initiation", 
      "proliferation", 
      "activity", 
      "activation", 
      "stage", 
      "accumulation", 
      "inhibitors", 
      "disruption", 
      "necessary step", 
      "subpopulations", 
      "markers", 
      "establishment", 
      "progression", 
      "interaction", 
      "patterns", 
      "cycle", 
      "development", 
      "presence", 
      "factors", 
      "profile", 
      "step", 
      "interference", 
      "process", 
      "promise", 
      "transition", 
      "data", 
      "medicine", 
      "stabilisation", 
      "phase", 
      "manuscript"
    ], 
    "name": "A critical role for p38MAPK signalling pathway during reprogramming of human fibroblasts to iPSCs", 
    "pagination": "41693", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1083524755"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/srep41693"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28155868"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/srep41693", 
      "https://app.dimensions.ai/details/publication/pub.1083524755"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T17:04", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_723.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/srep41693"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/srep41693'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/srep41693'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/srep41693'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/srep41693'


 

This table displays all metadata directly associated to this object as RDF triples.

271 TRIPLES      21 PREDICATES      133 URIs      113 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/srep41693 schema:about N098399f1173e4d56abe0eb0f673b51b6
2 N4151ed0d1e2e403ba775c86765248ff8
3 N6179608b1e0b41d18a5f9a9372519586
4 N6dd5ed8129224493a1bd0999355a6fcc
5 N713c2f8609be480e9d7d49ecd3e277ae
6 N813d47b7c3824b66acb8b54d80c05dd5
7 Na9e5b7da4e3f489eb72d2990d714aff5
8 Naf592c3b654f4f8a861ccd65fef2eeb1
9 Nc0dba13b8fd44c2f90c353b5c47d9450
10 Nf1ce80bfd7c1402b8aa467bd4c624a66
11 Nfb347c2b809c4af0855e73e9a67ea86e
12 Nffbbb3d8a28449afa2f53428e1bd39e7
13 anzsrc-for:06
14 anzsrc-for:0601
15 anzsrc-for:0604
16 schema:author Nce6b58822868422facae3ee2e3fd2639
17 schema:citation sg:pub.10.1038/cddis.2014.464
18 sg:pub.10.1038/cr.2012.143
19 sg:pub.10.1038/nature09531
20 sg:pub.10.1038/nature14047
21 sg:pub.10.1038/nature14607
22 sg:pub.10.1038/ncb3207
23 sg:pub.10.1038/nchembio.1552
24 sg:pub.10.1038/ncomms2059
25 sg:pub.10.1038/ncomms4678
26 sg:pub.10.1038/onc.2008.358
27 sg:pub.10.1038/onc.2011.656
28 schema:datePublished 2017-02-03
29 schema:datePublishedReg 2017-02-03
30 schema:description Reprogramming of somatic cells to induced pluripotent stem cells (iPSCs) holds enormous promise for regenerative medicine. Reprogramming is a stepwise process with well-defined stages of initiation, maturation and stabilisation which are critically dependent on interactions between key pluripotency transcription factors, epigenetic regulators and signalling pathways. In this manuscript we have investigated the role of p38 MAPK signalling pathway and have shown a subpopulation- and phase-specific pattern of activation occurring during the initiation and maturation stage of reprogramming in partially and fully reprogrammed cells respectively. Downregulation of p38 MAPK activity via RNA interference or small molecule inhibitor led to cell accumulation in G1 phase of the cell cycle and reduced expression of cell cycle regulators during the initiation stage of reprogramming. This was associated with a significant downregulation of key pluripotency marker expression, disruption of mesenchymal to epithelial transition (MET), increased expression of differentiation markers and presence of partially reprogrammed cells which retained a typical gene expression profile of mesendodermal cells and were unable to progress to fully reprogrammed phenotype. Together our data indicate an important role for p38 MAPK activity in proliferation, MET progression and establishment of pluripotent phenotype, which are necessary steps for the development of human iPSCs.
31 schema:genre article
32 schema:isAccessibleForFree true
33 schema:isPartOf Ned0c71c725eb447085f297fca84331cf
34 Nef76aea302f94aeeb652932fc5eba222
35 sg:journal.1045337
36 schema:keywords G1 phase
37 MAPK
38 MAPK activity
39 MetS progression
40 RNA interference
41 accumulation
42 activation
43 activity
44 cell accumulation
45 cell cycle
46 cell cycle regulators
47 cells
48 critical role
49 cycle
50 cycle regulators
51 data
52 development
53 differentiation markers
54 disruption
55 downregulation
56 enormous promise
57 epigenetic regulators
58 epithelial transition
59 establishment
60 expression
61 expression profiles
62 factors
63 fibroblasts
64 gene expression profiles
65 human fibroblasts
66 human iPSC
67 iPSCs
68 important role
69 inhibitors
70 initiation
71 initiation stage
72 interaction
73 interference
74 key pluripotency transcription factors
75 manuscript
76 marker expression
77 markers
78 maturation
79 maturation stage
80 medicine
81 mesendodermal cells
82 molecule inhibitors
83 necessary step
84 p38 MAPK
85 p38 MAPK activity
86 p38MAPK
87 pathway
88 patterns
89 phase
90 phase-specific pattern
91 phenotype
92 pluripotency marker expression
93 pluripotency transcription factors
94 pluripotent phenotype
95 pluripotent stem cells
96 presence
97 process
98 profile
99 progression
100 proliferation
101 promise
102 reduced expression
103 regenerative medicine
104 regulator
105 reprogramming
106 role
107 significant downregulation
108 small molecule inhibitors
109 somatic cells
110 stabilisation
111 stage
112 stage of initiation
113 stem cells
114 step
115 stepwise process
116 subpopulations
117 transcription factors
118 transition
119 typical gene expression profiles
120 schema:name A critical role for p38MAPK signalling pathway during reprogramming of human fibroblasts to iPSCs
121 schema:pagination 41693
122 schema:productId N511b298481854c8aa1e408c4b5a01da8
123 Nd1d0aff139994e709ca02007f1b4dabf
124 Nddc5b8d8a3704a1da1ed80756f663d47
125 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083524755
126 https://doi.org/10.1038/srep41693
127 schema:sdDatePublished 2022-08-04T17:04
128 schema:sdLicense https://scigraph.springernature.com/explorer/license/
129 schema:sdPublisher Ne70cb2c9091044459136a4bfcd852569
130 schema:url https://doi.org/10.1038/srep41693
131 sgo:license sg:explorer/license/
132 sgo:sdDataset articles
133 rdf:type schema:ScholarlyArticle
134 N098399f1173e4d56abe0eb0f673b51b6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Humans
136 rdf:type schema:DefinedTerm
137 N4151ed0d1e2e403ba775c86765248ff8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name MAP Kinase Signaling System
139 rdf:type schema:DefinedTerm
140 N511b298481854c8aa1e408c4b5a01da8 schema:name dimensions_id
141 schema:value pub.1083524755
142 rdf:type schema:PropertyValue
143 N6179608b1e0b41d18a5f9a9372519586 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Protein Kinase Inhibitors
145 rdf:type schema:DefinedTerm
146 N68d5c64038a64bf1b549e83095f70abe rdf:first sg:person.01165132537.69
147 rdf:rest N99336ebad0de4eb795482f687a54968d
148 N6dd5ed8129224493a1bd0999355a6fcc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Gene Expression Regulation, Developmental
150 rdf:type schema:DefinedTerm
151 N713c2f8609be480e9d7d49ecd3e277ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Cells, Cultured
153 rdf:type schema:DefinedTerm
154 N758063c4ade1405e9bf1f80c022b0c35 rdf:first sg:person.01366133637.49
155 rdf:rest N68d5c64038a64bf1b549e83095f70abe
156 N813d47b7c3824b66acb8b54d80c05dd5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Cellular Reprogramming
158 rdf:type schema:DefinedTerm
159 N99336ebad0de4eb795482f687a54968d rdf:first sg:person.01007342000.45
160 rdf:rest rdf:nil
161 Na9e5b7da4e3f489eb72d2990d714aff5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Biomarkers
163 rdf:type schema:DefinedTerm
164 Naf592c3b654f4f8a861ccd65fef2eeb1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Cell Cycle
166 rdf:type schema:DefinedTerm
167 Nc0dba13b8fd44c2f90c353b5c47d9450 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Cell Line
169 rdf:type schema:DefinedTerm
170 Nce6b58822868422facae3ee2e3fd2639 rdf:first sg:person.01162446171.50
171 rdf:rest N758063c4ade1405e9bf1f80c022b0c35
172 Nd1d0aff139994e709ca02007f1b4dabf schema:name doi
173 schema:value 10.1038/srep41693
174 rdf:type schema:PropertyValue
175 Nddc5b8d8a3704a1da1ed80756f663d47 schema:name pubmed_id
176 schema:value 28155868
177 rdf:type schema:PropertyValue
178 Ne70cb2c9091044459136a4bfcd852569 schema:name Springer Nature - SN SciGraph project
179 rdf:type schema:Organization
180 Ned0c71c725eb447085f297fca84331cf schema:volumeNumber 7
181 rdf:type schema:PublicationVolume
182 Nef76aea302f94aeeb652932fc5eba222 schema:issueNumber 1
183 rdf:type schema:PublicationIssue
184 Nf1ce80bfd7c1402b8aa467bd4c624a66 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Epithelial-Mesenchymal Transition
186 rdf:type schema:DefinedTerm
187 Nfb347c2b809c4af0855e73e9a67ea86e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Induced Pluripotent Stem Cells
189 rdf:type schema:DefinedTerm
190 Nffbbb3d8a28449afa2f53428e1bd39e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Fibroblasts
192 rdf:type schema:DefinedTerm
193 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
194 schema:name Biological Sciences
195 rdf:type schema:DefinedTerm
196 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
197 schema:name Biochemistry and Cell Biology
198 rdf:type schema:DefinedTerm
199 anzsrc-for:0604 schema:inDefinedTermSet anzsrc-for:
200 schema:name Genetics
201 rdf:type schema:DefinedTerm
202 sg:grant.2757148 http://pending.schema.org/fundedItem sg:pub.10.1038/srep41693
203 rdf:type schema:MonetaryGrant
204 sg:grant.2769496 http://pending.schema.org/fundedItem sg:pub.10.1038/srep41693
205 rdf:type schema:MonetaryGrant
206 sg:grant.2785655 http://pending.schema.org/fundedItem sg:pub.10.1038/srep41693
207 rdf:type schema:MonetaryGrant
208 sg:grant.3791225 http://pending.schema.org/fundedItem sg:pub.10.1038/srep41693
209 rdf:type schema:MonetaryGrant
210 sg:grant.5135071 http://pending.schema.org/fundedItem sg:pub.10.1038/srep41693
211 rdf:type schema:MonetaryGrant
212 sg:journal.1045337 schema:issn 2045-2322
213 schema:name Scientific Reports
214 schema:publisher Springer Nature
215 rdf:type schema:Periodical
216 sg:person.01007342000.45 schema:affiliation grid-institutes:grid.1006.7
217 schema:familyName Lako
218 schema:givenName Majlinda
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01007342000.45
220 rdf:type schema:Person
221 sg:person.01162446171.50 schema:affiliation grid-institutes:grid.1006.7
222 schema:familyName Neganova
223 schema:givenName Irina
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162446171.50
225 rdf:type schema:Person
226 sg:person.01165132537.69 schema:affiliation grid-institutes:grid.1006.7
227 schema:familyName Armstrong
228 schema:givenName Lyle
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01165132537.69
230 rdf:type schema:Person
231 sg:person.01366133637.49 schema:affiliation grid-institutes:grid.1006.7
232 schema:familyName Chichagova
233 schema:givenName Valeria
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01366133637.49
235 rdf:type schema:Person
236 sg:pub.10.1038/cddis.2014.464 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015071629
237 https://doi.org/10.1038/cddis.2014.464
238 rdf:type schema:CreativeWork
239 sg:pub.10.1038/cr.2012.143 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053268375
240 https://doi.org/10.1038/cr.2012.143
241 rdf:type schema:CreativeWork
242 sg:pub.10.1038/nature09531 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025900132
243 https://doi.org/10.1038/nature09531
244 rdf:type schema:CreativeWork
245 sg:pub.10.1038/nature14047 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006413691
246 https://doi.org/10.1038/nature14047
247 rdf:type schema:CreativeWork
248 sg:pub.10.1038/nature14607 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011151247
249 https://doi.org/10.1038/nature14607
250 rdf:type schema:CreativeWork
251 sg:pub.10.1038/ncb3207 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032373249
252 https://doi.org/10.1038/ncb3207
253 rdf:type schema:CreativeWork
254 sg:pub.10.1038/nchembio.1552 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023910067
255 https://doi.org/10.1038/nchembio.1552
256 rdf:type schema:CreativeWork
257 sg:pub.10.1038/ncomms2059 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005754768
258 https://doi.org/10.1038/ncomms2059
259 rdf:type schema:CreativeWork
260 sg:pub.10.1038/ncomms4678 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003699666
261 https://doi.org/10.1038/ncomms4678
262 rdf:type schema:CreativeWork
263 sg:pub.10.1038/onc.2008.358 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021627237
264 https://doi.org/10.1038/onc.2008.358
265 rdf:type schema:CreativeWork
266 sg:pub.10.1038/onc.2011.656 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024757614
267 https://doi.org/10.1038/onc.2011.656
268 rdf:type schema:CreativeWork
269 grid-institutes:grid.1006.7 schema:alternateName Institute of Genetic Medicine, Newcastle University, International Centre for Life, NE1 3BZ, UK
270 schema:name Institute of Genetic Medicine, Newcastle University, International Centre for Life, NE1 3BZ, UK
271 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...